Nope, they didn't say it does not have health risks. They just said it should not be more strictly controlled.
It has been reported the certain drugs, including carfentanil, is up for scheduling or being put into strict drug control measures. And despite of being heated on, medical marijuana is not on the list.
This is recommended by the Expert Committee on Drug Dependence (ECDD) and is endorsed by the World Health Organization (WHO).
“There is increased interest from Member States in the use of cannabis for medical indications including for palliative care,” the WHO writes. “Responding to that interest and increase in use, WHO has in recent years gathered more robust scientific evidence on therapeutic use and side effects of cannabis and cannabis components.”
They said an initial review of the cannabidiol (CBD) has already been done by the ECDD and that recent data on animal and human studies have shown “that its use could have some therapeutic value for seizures due to epilepsy and related conditions.”
They added that it was “not likely to be abused or create dependence as for other cannabinoids”. But, again, they never mentioned that this has “no health risks". Instead, ECDD announced that the current studies still can justify scheduling cannabidiol. So, look out this May for a more comprehensive review about cannabidiol will be released.
As to a drug called carfentanil (an analogue of the prescription opioid fentanyl), however, the future won't be so bright. EDCC recommended this to be placed under the most stringent level of international control, which is Schedules I and IV.
“Carfentanil can produce lethal effects at extremely small doses equivalent to a few granules of salt, and has potential use as a chemical weapon,” the WHO writes. “It can thus be highly toxic and has been associated with hundreds of deaths and intoxications, notably in North America,” they added, noting that in just 2016 alone, 64,000 people in the US died from overdosing.
Get weekly science updates in your inbox!